NUK - logo
E-viri
Celotno besedilo
Recenzirano Odprti dostop
  • MRI- and Histologic-Molecul...
    Celli, Veronica; Guerreri, Michele; Pernazza, Angelina; Cuccu, Ilaria; Palaia, Innocenza; Tomao, Federica; Di Donato, Violante; Pricolo, Paola; Ercolani, Giada; Ciulla, Sandra; Colombo, Nicoletta; Leopizzi, Martina; Di Maio, Valeria; Faiella, Eliodoro; Santucci, Domiziana; Soda, Paolo; Cordelli, Ermanno; Perniola, Giorgia; Gui, Benedetta; Rizzo, Stefania; Della Rocca, Carlo; Petralia, Giuseppe; Catalano, Carlo; Manganaro, Lucia

    Cancers, 11/2022, Letnik: 14, Številka: 23
    Journal Article

    High- and low-risk endometrial carcinoma (EC) differ in whether or not a lymphadenectomy is performed. We aimed to develop MRI-based radio-genomic models able to preoperatively assess lymph-vascular space invasion (LVSI) and discriminate between low- and high-risk EC according to the ESMO-ESGO-ESTRO 2020 guidelines, which include molecular risk classification proposed by "ProMisE". This is a retrospective, multicentric study that included 64 women with EC who underwent 3T-MRI before a hysterectomy. Radiomics features were extracted from T2WI images and apparent diffusion coefficient maps (ADC) after manual segmentation of the gross tumor volume. We constructed a multiple logistic regression approach from the most relevant radiomic features to distinguish between low- and high-risk classes under the ESMO-ESGO-ESTRO 2020 guidelines. A similar approach was taken to assess LVSI. Model diagnostic performance was assessed via ROC curves, accuracy, sensitivity and specificity on training and test sets. The LVSI predictive model used a single feature from ADC as a predictor; the risk class model used two features as predictors from both ADC and T2WI. The low-risk predictive model showed an AUC of 0.74 with an accuracy, sensitivity, and specificity of 0.74, 0.76, 0.94; the LVSI model showed an AUC of 0.59 with an accuracy, sensitivity, and specificity of 0.60, 0.50, 0.61. MRI-based radio-genomic models are useful for preoperative EC risk stratification and may facilitate therapeutic management.